Lessons from cancer evolution for the clinic
The first long-term study of how lung cancer evolves is revealing that therapies targeting multiple proteins in tumour cells could help to outpace the disease. Charles Swanton is the chief investigator of TRACERx, a study that is tracking 840 people from the moment of diagnosis. He explains how the project’s findings can help clinicians stay one step ahead of cancer.
Nature | 9 min read
No hay comentarios:
Publicar un comentario